ANGELA PRICE: Open Payments
NPI 1346869690 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$270 in 11 payments from 8 companies in 2025. Trend: 2023 $206 · 2024 $470 · 2025 $270
Food & beverage: $270
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 2 | $59 |
| Organon LLC | 2 | $58 |
| Exeltis, USA Inc. | 2 | $51 |
| Astellas Pharma US Inc | 1 | $30 |
| PFIZER INC. | 1 | $23 |
| Evofem Biosciences, Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $16 |
| ABBVIE INC. | 1 | $14 |
Products named: NEXPLANON, SLYND, KEYTRUDA, Veozah, GARDASIL 9, ABRYSVO, Phexxi, The Cologuard Plus Collection Kit.
Industry payments across MD — which companies pay providers there.
